CRSP
CRISPR Therapeutics AG · Healthcare
CEO Samarth Kulkarni sold $1.4M of CRISPR Therapeutics AG
Sold$1,350,827
$54.03Price
25,000Shares
−8%Stake
What CRSP did after the filing
- The stock from Wed, Nov 30 close, $54.79
- −8.9%
- S&P 500, same days
- −1.8%
Measured over 30 trading days, to the Jan 13 close.
Traded Mon, Nov 28. Filed Wed, Nov 30, 12:36 PM ET, during the session. Returns use the Nov 30 close and the Jan 13 close. Not investment advice.